The entrepreneur is on a mission to combat the mental health crisis by making psychedelics accepted in society.
As soon as Christian Angermayer, one of Europe’s most successful entrepreneurs and investors, signs onto our Zoom call on a Saturday morning, he’s upbeat and excited to dive into various topics he’s passionate about, one of them being his quest for longevity and happiness.
The self-made billionaire founder of Apeiron Investment Group, a global investment firm focused on tech and biotech investments, grew up in a 90-person village in Germany and has stayed busy from a young age.
At 14, he had his first entrepreneurial idea in the form of a tutoring company. Today, Apeiron owns stakes in more than 100 companies globally including well-known brands like CBD beverage TRIP, hotel group Aethos and home fitness device company FORME LIFE.
Styled by ADELE CANY
Photographs assisted by MARIANA DEROUDILHE Grooming by PHOEBE TAYLOR
But his main passion is biotech. With more than $3 billion under management through his Apeiron Investment Group, the entrepreneur created biotech companies ATAI Life Sciences, Cambrian BioPharma and Rejuveron Life Sciences, building on his belief that everyone wants to live healthier, happier and longer lives.
“I’ve always believed aging in itself is a disease, so why not find a cure for it?” Angermayer, 44, exclusively tells GRAZIA USA. “With Cambrian and Rejuveron, we are working hard to discover therapeutics to mitigate the aging process. I am very confident we soon will be able to slow down and even reverse aging and push life expectancy up significantly.”
To read more about Angermayer‘s mission, read his full profile here.
